Fact CheckerSign in

NCT05753761Completed

The Whole Day Matters After Stroke (BIG-STEPS)

The Whole Day Matters After Stroke: Moving Towards Precision Rehabilitation Guided by Behavioural and Imaging Markers

Source: ClinicalTrials.gov · Last updated 13 Apr 2026

Brief summary (registry, in English)

Goal of research program: To understand person-specific factors, such as imaging markers and activity patterns early after stroke, that may guide precision rehabilitation to optimize function and improve recovery. Objectives: 1. Test the effect of reducing sedentary behaviour early after stroke on functional mobility and global disability outcomes. 2. Determine the impact of neuroimaging biomarkers (e.g. leukoaraiosis) on response to rehabilitation. 3. Explore the predictive value of accelerometry as an adjunct to the subjective modified Rankin Scale (mRS) to assess functional disability after stroke. Experimental approach/Research Plan/Use of Funds: The investigators aim to recruit 50 participants within 3 months of stroke onset, aged ≥ 18 years, medically stable as deemed by their physicians, able to walk at least 5 meters with/without gait aid and with ongoing walking or balance goals. Demographic and stroke characteristics, including stroke risk factors, infarct location and volume, leukoaraiosis on routine MRI, and acute stroke treatments (e.g., thrombectomy) will be determined and documented. A battery of impairment, psychosocial, and functional measures, including the mRS and Timed-Up and Go test (primary outcomes) will be completed. Subsequently, participants will be set up to wear activPAL accelerometer, validated in stroke, for 1 week. Following randomization, a sedentary behaviour change intervention will span 6 weeks, with final follow-up assessments at 90 days.

Status (registry)
Completed
Study type
Interventional
Enrollment
55 (actual)
First submitted
10 Feb 2023
Start date
10 Jul 2023
Primary completion date
26 Nov 2025
Lead sponsor
University of Alberta
Diseases
Stroke
NCT number
NCT05753761

What you commit to

  • Study type: Interventional
  • Participants enrolled: 55
  • From 10 Jul 2023 to the primary completion date, 26 Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have another condition such as multiple sclerosis or Parkinson's disease, or active cancer
  • Unstable cardiovascular condition

Other

  • Uncontrolled high blood pressure
  • Unable to understand or follow instructions.

Who the study is looking for

  • Within 3 months of stroke onset
  • Aged ≥ 18 years
  • Medically stable as deemed by physicians
  • Able to walk at least 5 meters with/without gait aid
  • Ongoing walking goals (walk speed \<1.0 meter/sec)

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alberta Hospital
Coordinator of this site? Confirm its status
EdmontonCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.